follows the recommendations developed by Di abetes Poland.
Inclusion criteria We included patients with di abetes diagnosed according to the 1999 World Health Organization criteria, for whom it was pos sible to continue a followup study for 1 to 3 years, with control visits at least every 6 months. recruitment of clinicians and their patients Phy sicians working in diabetes clinics were invited to participate in the study by the study sponsor. They were shown how to use data collection sys tem and were equipped with pocket PCs (Dell Axim X30, Dell, Poland). This device was preload ed with software developed for the purposes of this study, including electronic questionnaire auto matically saving patient information. In or der to become a study investigator, each physi cian had to include at least 10 patients during months 0-6 of the study, which began in 2006, and continue their observation for 3 years or till the end of the study. Patients fulfilling the in clusion criteria were recruited in pseudo random manner, i.e., the last 2 patients registered for the day were to be included. Patients with new ly diagnosed diabetes were not eligible to enter the study according to the protocol. Patients in cluded in the study were to attend followup visits at least every 6 months. All of the physicians reg ularly received educational content in the form of a short multimedia presentation for pocket PCs, and they were randomly assigned to receive (or not to receive) additional information appearing during visits while entering new data. Those short messages were designed to increase practitioners' awareness of certain guideline recommendations, relevant to individual patients.
At baseline, the questionnaire included ques tions concerning physicians (specialization and years since graduation) and patients (age, sex, height, place of residence, diabetes diagnosis [di abetes type], time from diagnosis, time from in sulin initiation in those receiving insulin, par ticipation in training for patients with diabetes, presence of diabetic complications [nephropathy, neuropathy, diabetic foot, coronary heart dis ease [CHD] , hypertension, and stroke according to the report of an investigating physician], and smoking history). At each visit, the questionnaire contained the following items: weight, blood pres sure (BP), the result of foot examination, informa tion on newly diagnosed diabetic complications (hypertension, nephropathy, retinopathy, neurop athy, CHD, and stroke), current smoking status, information on diabetes control (current HbA 1c , hospitalizations due to diabetes or severe epi sodes of hypoglycemia), information on current treatment (diabetic drugs, antihypertensive drugs, antiplatelet drugs, and lipid lowering drugs). Pe riodically (as reminders were sent), the question naire included additional items: lipid profile, test ing for diabetic nephropathy, retinopathy, testing for diabetic foot (at each visit), and information to patient care, it is individual patients and clini cians who make decisions and treatment choic es, and individual patients who actually achieve (or not) the treatment goals. Although patients' age, diabetes duration, comorbidities, and life style 7 have all been linked to the level of glycemic control, much less is known of the key factors in volved in the process of translation of guideline recommendations to actual patient care. While practitioners generally follow the guidelines, they may have their own preferences or limita tions in their full implementation. The aim of the OPTIMO study was to prospectively observe a large population of diabetic patients in Poland and to assess whether providing additional med ical information to practitioners improves com pliance with the guidelines as measured by glu cose, lipid, and hypertension control in diabetic patients. In this paper, we present the baseline characteristics of the study population.
The OPTIMO study consisted of 3 elements: 1 observational study aimed to collect data on the characteristics of diabetic patients treated in diabetes clinics across Poland, based on an elec tronic questionnaire for physicians 2 clinical decision support system (CDSS) pro vided to randomly selected physicians participat ing in the project, integrated with the electron ic questionnaire 3 educational program tailored to the needs of specialists; the program was regularly updated and evaluated with a short multiplechoice test.
The aims of the entire project were as follows: 1 to characterize diabetic patient population treated in diabetes clinics in Poland 2 to describe selected methods of treatment and care of diabetes and to assess their accor dance with clinical practice guidelines developed by Diabetes Poland 1 3 to implement CDSS in the care of diabetic pa tients and assess suitability of different CDSS ver sions using randomized approach 4 to introduce educational program tailored to the needs of specialists in diabetology 5 to improve information technology system aimed to improve the quality of specialist care on the basis of the collected data and physician's opinion.
PAtIEnts And mEthods This is the first arti cle in the series of planned publications present ing the results of the OPTIMO study. It describes the methodology of the OPTIMO observational study and the baseline characteristics of the in cluded patients. Data collection was scheduled to take 3 years. the aims of the paper This article provides data on the study protocol, the baseline characteris tics of the patients and participating physicians, as well as on the baseline management of pa tients with different types of diabetes. It also shows to what extent management of diabetes the ShapiroWilk test. All statistical analyses were conducted using SPSS v. 17.0.
rEsuLts The study involved 369 physicians. Most of them were specialized in inter nal medi cine; 20% in diabetology (tAbLE 1).
Most physicians graduated 11 to 20 years be fore the study onset (tAbLE 2) .
Median number of patients per physician was 27 (mean 26) and median number of visits per physician was 50 (mean 76). Median number of visits per patient for each physician was 1.9 (mean 2.7).
Altogether, we received 9600 valid baseline questionnaires. The majority of patients partic ipating in the study had type 2 diabetes (over 8500), but the group of patients with type 1 di abetes was also large (over 500 patients). Only 4 patients had gestational diabetes and 5 patients were diagnosed with maturity onset diabetes of the young (MODY). Latent auto immune diabe tes in adults (LADA diabetes) was diagnosed in 80 patients and secondary diabetes due to pan creatic disorders in 94 patients. Most patients with all types of diabetes were treated by physi cians specialized in inter nal medicine or diabe tology (tAbLE 3) .
In overall population, the mean age of patients was 60.5 years and 54% were women. Reported lipid levels were above the values recommend ed in practice guidelines for diabetic patients (tAbLE 4). Median HbA 1c was also above the lev el recommended in the guidelines (7.1%). Over 31% of the patients had CHD and over 76% had hypertension. Patient characteristics are present ed in tAbLE 4.
The frequency of diabetic complications (on the basis of medical history) in the total popula tion is shown in FIGurE 1 ; the frequency depending on duration of the disease and the type of diabe tes is described in tAbLE 5 and tAbLE 6, respectively. The most common complication was retinopathy, followed by neuropathy. More than 20% of the pa tients were not examined for diabetic nephrop athy, neuropathy, and retinopathy and only 5% were not examined for diabetic foot. In the analy sis of meeting diabetes treatment goals in the total on the followup of patients who completed their participation in the program.
Data entered by physicians were saved on the memory cards, which were subsequently transferred to the study data coordinating cen ter and immediately returned with a new educa tional content added. Data were saved and kept in a way preventing identification of patientsonly the patient's code was entered and the data from data memory card could have been read only with individual Pocket PC of the physician who took care of the patient, or in the study data co ordinating center. statistical analysis Results are presented as mean with standard deviation (SD) or medians with inter quartile range (numerical variables) or as percentage (categorical variables).
The distribution was estimated on the basis of skewness coefficient, graphical picture and dIscussIon The prevalence of type 2 diabetes is increasing at an alarming rate, and the incidence of diabetes in Poland is comparable to the aver age values observed worldwide. 8 Despite the prog ress in treatment options and availability of glu cose monitoring devices, the disease control re mains a challenge. Median HbA 1c for the whole group of 9600 diabetic patients was 7.1% (in terquartile range 2), and it was nearly the same as in the smaller study assessing the implemen tation of Diabetes Poland recommendations in patients treated in similar outpatient setting, but in 1 center only, in 2007. 9 Mean BP values (136/82 mmHg vs. 136/79 mmHg) were also quite similar, but LDL cholesterol levels were not (130.5 vs. 105.5 mg/dl). In "The Improvement of Glyce mic Control" program, diabetic patients referred to specialists by general practitioners had even higher HbA 1c (mean 8.8%; <7% in only 18.5% of the patients) and BP (mean 140/83 mmHg), and worse lipid profile despite the same percentage of patients achieving LDL cholesterol target. 10 In the DINAMIC2 program, mean HbA 1c levels were slightly higher than in the present study (7.37% vs. 7.1%) and there was lower percentage of pa tients meeting BP goal <130/80 mmHg (5.16% vs. 10.7%).
11 Other studies in the Polish popula tion also showed that the HbA 1c target values are consistently achieved only by a minority of pa tients, [10] [11] [12] [13] [14] [15] and there are similar findings in oth er countries. 16, 17 Current standards of care indi cate the need for regular tests to diagnose and ob serve diabetic complications. The study revealed that more than 20% of the patients had not been examined previously for diabetic microvascu lar complications, including diabetic nephropa thy, neuropathy, and retinopathy. There is an ev ident gap between the treatment goals described in the recommendations of care and the actual health care achievements, and it seems important to find new ways of translating diabetes guide lines into practice. Before we learn how to do it, we should understand the real problems of reach ing and maintaining optimal control of diabetes. The initial results of the OPTIMO study present ed here addressed these problems in the setting of Polish diabetes clinics, giving baseline charac teristics of 9600 patients and 369 participating physicians. Considerable deviations from treat ment targets that are recommended by current population, we observed that only 23% of the pa tients had HbA 1c levels below 6.5% recommended in practice guidelines (FIGurE 2). When less strict goal was applied (≤7.0%), the number increased to 44%. Total cholesterol and triglyceride treatment goals (<4.5 mmol/l and <1.7 mmol/l, respectively) Abbreviations: see at the time of the study there was no higher tar get HbA 1c than that of 6.5%. Of note, the study was not designed to collect data on laboratory methods used in HbA 1c assays, so there is uncertainty as to the accuracy of all HbA 1c results from different centers in Poland. Diabetes Poland recommends that the methods used in HbA 1c assays should be certified by the Na tional Glycohemoglobin Standardization Program, and this is what we have assumed.
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to whether the clinical decision support system and educational program tailored to the needs of specialists proves helpful for clinicians and enables them to meet therapeutic goals and im prove diabetes care. study limitations The system of data collection might have been troublesome for some doctors; therefore, only those who agreed to collect data using pocket PC could participate in the study. The only way of reducing bias in patient selection was a pseudo random manner of patient recruit ment described above, and we consider this a lim itation to obtain reliable data. Another shortcom ing is that both HbA 1c and BP target values of Di abetes Poland practice guidelines have changed since the study was performed, becoming less stringent and more dependent on individual pa tients' characteristics. Although we calculated not only the proportions of patients meeting the pre vious goals (HbA 1c ≤6.5 and BP <130/80 mmHg) but also the new ones for the majority of patients (HbA 1c ≤7.0% and BP <140/90 mmHg), we did not show data for all HbA 1c treatment goals (≤6.1%; ≤6.5%, ≤7.0%, <8.0%) currently recommend ed by Diabetes Poland in the subgroups. 2 Al though HbA 1c <8.0% is now accepted in patients over 70 years of age with a long diabetes dura tion (>20 years) and a history of cardiovascular events, we did not use this treatment goal because 
